Lite Strategy, Inc. Reports Board and Officer Changes
Ticker: LITS · Form: 8-K · Filed: Nov 18, 2025 · CIK: 1262104
| Field | Detail |
|---|---|
| Company | Lite Strategy, INC. (LITS) |
| Form Type | 8-K |
| Filed Date | Nov 18, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.00000002, $2.02 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, officer-appointment, director-election, compensation
Related Tickers: LIT
TL;DR
Lite Strategy (LIT) board shakeup, new exec comp details filed.
AI Summary
Lite Strategy, Inc. announced on November 14, 2025, changes related to its board of directors and officers, including the departure of certain individuals and the election of new directors. The company also reported on compensatory arrangements for its officers. This filing follows a period of corporate activity for the company, formerly known as MEI Pharma, Inc.
Why It Matters
Changes in a company's leadership and executive compensation can signal shifts in strategy or operational focus, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in directors and officers, especially without detailed explanations, can introduce uncertainty about the company's future direction and stability.
Key Players & Entities
- Lite Strategy, Inc. (company) — Registrant
- MEI Pharma, Inc. (company) — Former company name
- November 14, 2025 (date) — Date of earliest event reported
- November 18, 2025 (date) — Filing date
FAQ
What specific roles have been affected by the director and officer changes?
The filing indicates changes in 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' but does not specify the exact roles affected in the provided text.
Were there any specific reasons cited for the departure of directors or officers?
The provided text does not detail the reasons for any departures of directors or officers.
What are the key details of the compensatory arrangements for certain officers?
The filing mentions 'Compensatory Arrangements of Certain Officers' as an item reported, but the specific details of these arrangements are not included in the provided text.
When was Lite Strategy, Inc. formerly known as MEI Pharma, Inc.?
Lite Strategy, Inc. was formerly known as MEI Pharma, Inc. with a date of name change on June 29, 2012.
What is the principal executive office address for Lite Strategy, Inc.?
The principal executive offices are located at 9920 Pacific Heights Blvd., Suite 150, San Diego, California, 92121.
Filing Stats: 740 words · 3 min read · ~2 pages · Grade level 10.6 · Accepted 2025-11-18 17:07:13
Key Financial Figures
- $0.00000002 — nge on which registered Common Stock, $0.00000002 par value LITS The Nasdaq Stock Mar
- $2.02 — . The Options have an exercise price of $2.02 per share, which was the closing price
Filing Documents
- lits-20251114.htm (8-K) — 44KB
- 0001193125-25-286424.txt ( ) — 147KB
- lits-20251114.xsd (EX-101.SCH) — 24KB
- lits-20251114_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LITE STRATEGY, INC. Date: November 18, 2025 By: /s/ Justin J. File Chief Executive Officer, Chief Financial Officer and Secretarty